It has contributed immensely to the Korean pharmaceutical industry. In the times when Korean pharmaceutical companies relied entirely on import of medicine supplies, Chong Kun Dang was able to localize medicine supplies by establishing the largest compose and fermentation factories in Korea. Also, Chong Kun Dang was the first domestic company to obtain the U.S FDA approval, which marked the beginning of Korea’s medicine supplies export. Chong Kun Dang is celebrating its 78th anniversary and continues to make strides as a global pharmaceutical company through innovation and change.
Link to CKD PharmCEO |
Young-Joo, Kim |
---|---|
Foundation |
May 7, 1941 (Split up: November 5, 2013) |
Business Line |
Manufacturing/Sales of Medicine Supplies |
Paid in Capital |
31,421 (million won) |
Address |
8, Chungjeong-ro, Seodaemun-gu, Seoul, Korea |
TEL / FAX |
82-2-2194-0300 / 82-2-2194-0369 |